MicroPhage, Inc., a platform diagnostic technology company, develops medical diagnostics for bacterial identification and antibiotic susceptibility/resistance testing. Its products include methicillin-susceptible Staphylococcus aureus (MSSA)/methicillin-resistant Staphylococcus aureus (MRSA) blood culture tests, MRSA screening tests, andMRSA/MSSA screening tests. The company was founded in 2002 and is based in Longmont, Colorado.

Biotechnology

Health Diagnostics

Pharmaceutical

MicroPhage, Inc.

MicroPhage, Inc.'s headquarters in Longmont, CO, United States

Description

People (1)

Jobs (0)

Other offices